Pharmacology
Conference Coverage
Nonsteroidal topical found effective for psoriasis in 52-week study
“This is likely to be very useful in patients who are looking for a topical therapy for skin folds or the face, where there is a need for well-...
Conference Coverage
Antibody cocktail reduces chance of developing COVID
Conference Coverage
Oteseconazole promising for recurrent yeast infections
Oteseconazole was superior to fluconazole/placebo in the proportion of subjects with at least one culture-verified acute vulvovaginal candidiasis...
Latest News
FDA approval for tisotumab vedotin in advanced cervical cancer
The mainstay of therapy in this setting is monotherapy with chemotherapy, but the benefit-risk profiles are poor, and overall response rates are...
News
Relapse risk increased with antidepressant discontinuation
But patients can discontinue their antidepressants safely in primary care without relapsing, with a tapering regime, say the authors of a new...
News
Polyethylene glycol linked to rare allergic reactions seen with mRNA COVID-19 vaccines
Conference Coverage
Study supports chemotherapy with immunotherapy for some never-smokers with lung cancer
Although patients with PD-L1 expression below 50% derive clear benefit from combination versus single-agent therapy, treatment selection overall...
News
‘Alarming’ increase in fake pills laced with fentanyl, methamphetamine, DEA warns
More than 9.5 million fake pills have been seized so far this year – more than the last 2 years combined.
Conference Coverage
Should Geriatric Veterans Get Immunotherapy?
Latest News
FDA approves first oral drug for NSCLC with EGFR Exon 20 insertion
Mobocertinib is the first oral tyrosine kinase inhibitor for patients with metastatic non–small cell lung cancer who have an EGFR Exon 20...